Detalhe da pesquisa
1.
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Blood;
141(19): 2307-2315, 2023 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36821768
2.
A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic.
Acta Haematol;
146(2): 144-150, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36446346
3.
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
Cancer;
126(3): 567-574, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31769871
4.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
N Engl J Med;
377(26): 2531-2544, 2017 12 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29226797
5.
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Blood;
132(14): 1507-1518, 2018 10 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30104217
6.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Lancet Oncol;
20(1): 31-42, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30518502
7.
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center.
Biol Blood Marrow Transplant;
25(6): e199-e203, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30769194
8.
Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Blood;
135(23): 2106-2109, 2020 06 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32181801
9.
Autologous stem cell transplantation in an older adult population.
Haematologica;
107(9): 2261-2265, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35615933
10.
Stimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: A pilot study.
Am J Hematol;
92(10): 1047-1051, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28675459
11.
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Biol Blood Marrow Transplant;
22(7): 1197-1205, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27040394
12.
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.
Br J Haematol;
190(3): e130-e133, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32479664
13.
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
Clin Cancer Res;
29(15): 2774-2780, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37341641
14.
Global Longitudinal Strain Is Associated with Mortality in Patients with Multiple Myeloma.
J Clin Med;
12(7)2023 Mar 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37048679
15.
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.
Clin Cancer Res;
29(1): 60-66, 2023 01 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36255372
16.
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.
Blood;
116(7): 1025-34, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20427703
17.
Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML.
Exp Hematol Oncol;
10(1): 1, 2021 Jan 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33397455
18.
Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort.
Exp Hematol Oncol;
10(1): 55, 2021 Dec 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34886908
19.
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data.
Clin Lymphoma Myeloma Leuk;
21(4): e384-e397, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33339770
20.
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.
Blood Adv;
5(20): 4149-4155, 2021 10 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34478487